Invesco’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $222K | Buy |
155,017
+15,531
| +11% | +$22.2K | ﹤0.01% | 3484 |
|
|
2025
Q1 | $223K | Buy |
139,486
+70,293
| +102% | +$112K | ﹤0.01% | 3458 |
|
|
2024
Q4 | $249K | Buy |
69,193
+4,647
| +7% | +$16.7K | ﹤0.01% | 3452 |
|
|
2024
Q3 | $368K | Sell |
64,546
-953
| -1% | -$5.43K | ﹤0.01% | 3334 |
|
|
2024
Q2 | $303K | Buy |
65,499
+26,963
| +70% | +$125K | ﹤0.01% | 3483 |
|
|
2024
Q1 | $315K | Sell |
38,536
-653,546
| -94% | -$5.34M | ﹤0.01% | 3494 |
|
|
2023
Q4 | $3.91M | Buy |
692,082
+635,691
| +1,127% | +$3.59M | ﹤0.01% | 2353 |
|
|
2023
Q3 | $105K | Buy |
56,391
+481
| +0.9% | +$895 | ﹤0.01% | 3694 |
|
|
2023
Q2 | $154K | Sell |
55,910
-13,549
| -20% | -$37.3K | ﹤0.01% | 3647 |
|
|
2023
Q1 | $218K | Buy |
69,459
+53,233
| +328% | +$167K | ﹤0.01% | 3588 |
|
|
2022
Q4 | $95.7K | Sell |
16,226
-30
| -0.2% | -$177 | ﹤0.01% | 3810 |
|
|
2022
Q3 | $142K | Buy |
16,256
+2,401
| +17% | +$21K | ﹤0.01% | 3742 |
|
|
2022
Q2 | $105K | Sell |
13,855
-124,557
| -90% | -$944K | ﹤0.01% | 3848 |
|
|
2022
Q1 | $3.36M | Sell |
138,412
-325,790
| -70% | -$7.9M | ﹤0.01% | 2558 |
|
|
2021
Q4 | $14.9M | Sell |
464,202
-6,321
| -1% | -$204K | ﹤0.01% | 1745 |
|
|
2021
Q3 | $21M | Buy |
470,523
+1,128
| +0.2% | +$50.4K | 0.01% | 1535 |
|
|
2021
Q2 | $17.8M | Sell |
469,395
-140,324
| -23% | -$5.31M | ﹤0.01% | 1694 |
|
|
2021
Q1 | $22.6M | Buy |
609,719
+309,177
| +103% | +$11.4M | 0.01% | 1454 |
|
|
2020
Q4 | $9.96M | Buy |
+300,542
| New | +$9.96M | ﹤0.01% | 1814 |
|